Stock Earnings

Question 1

Quels sont les états financiers clés de ACADIA Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), ACADIA Pharmaceuticals Inc a un total d'actifs de $1,187, un bénéfice net profit de $226

Question 2

Quels sont les ratios financiers clés pour ACAD ?

Accepted Answer

Le ratio de liquidité de ACADIA Pharmaceuticals Inc est 2.61, la marge nette est 23.61, les ventes par action sont de $5.75.

Question 3

Comment les revenus de ACADIA Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

ACADIA Pharmaceuticals Inc largest revenue segment is Innovative Medicines, at a revenue of 957,797,000 in the most earnings release.For geography, United States is the primary market for ACADIA Pharmaceuticals Inc, at a revenue of 957,797,000.

Question 4

ACADIA Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, ACADIA Pharmaceuticals Inc a un bénéfice net profit de $226

Question 5

ACADIA Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

yes, ACADIA Pharmaceuticals Inc a un passif de 454

Question 6

Combien d'actions en circulation ACADIA Pharmaceuticals Inc a-t-elle ?

Accepted Answer

ACADIA Pharmaceuticals Inc a un total d'actions en circulation de 166.7

Breakdown	TTM	12/31/2024	09/30/2024	12/31/2023	09/30/2023	12/31/2022
Revenue	1,047	957	0	726	-2	517
Revenue Growth (YoY)	122%	--	-100%	-72,700%	-100%	-51,800%
Cost of Revenue	84	81	0	41	--	10
Gross Profit	962	875	0	684	--	507
Selling, General & Admin	523	488	0	406	0	369
Research & Development	344	303	--	351	--	361
Operating Expenses	721	791	0	758	0	730
Other Non Operating Income (Expenses)	2	1	--	5	--	3
Pretax Income	273	258	-2	-51	-2	-213
Income Tax Expense	12	31	0	10	0	2
Net Income	261	226	-2	-61	-3	-216
Net Income Growth	243%	-11,400%	-97%	6,000%	-95%	21,500%
Shares Outstanding (Diluted)	170.65	166.36	187.33	163.81	7.5	161.7
Shares Change (YoY)	-16%	-11%	14%	2,738%	-95%	2,701%
EPS (Diluted)	1.53	1.36	-0.01	-0.37	-0.43	-1.34
EPS Growth	314%	-11,257%	-97%	86%	15%	568%
Free Cash Flow	216	157	-1	-23	0	-114
Free Cash Flow Per Share	1.26	0.94	0	-0.14	0	-0.7
Gross Margin	91.88%	91.43%	0%	94.21%	--	98.06%
Operating Margin	22.92%	8.77%	0%	-10.05%	100%	-43.13%
Profit Margin	24.92%	23.61%	0%	-8.4%	150%	-41.77%
Free Cash Flow Margin	20.63%	16.4%	0%	-3.16%	0%	-22.05%
EBITDA	264	99	--	-68	--	-221
EBITDA Margin	25.21%	10.34%	--	-9.36%	--	-42.74%
D&A For EBITDA	24	15	--	5	--	2
EBIT	240	84	-1	-73	-2	-223
EBIT Margin	22.92%	8.77%	0%	-10.05%	100%	-43.13%
Effective Tax Rate	4.39%	12.01%	0%	-19.6%	0%	-0.93%

ACADIA Pharmaceuticals Inc (ACAD) Price

ACAD Stock Price Chart

ACAD Income

Follow-Up Questions